- Home
- WDC vs ILMN Comparison
WDC vs ILMN Comparison
Compare WDC & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WDC
- ILMN
- Stock Information
- Founded
- WDC 1970
- ILMN 1998
- Country
- WDC United States
- ILMN United States
- Employees
- WDC N/A
- ILMN N/A
- Industry
- WDC Electronic Components
- ILMN Medical Specialities
- Sector
- WDC Technology
- ILMN Health Care
- Exchange
- WDC Nasdaq
- ILMN Nasdaq
- Market Cap
- WDC 24.7B
- ILMN 23.6B
- IPO Year
- WDC N/A
- ILMN 2000
- Fundamental
- Price
- WDC $61.71
- ILMN $134.96
- Analyst Decision
- WDC Buy
- ILMN Buy
- Analyst Count
- WDC 21
- ILMN 17
- Target Price
- WDC $87.89
- ILMN $163.12
- AVG Volume (30 Days)
- WDC 5.5M
- ILMN 2.1M
- Earning Date
- WDC 01-23-2025
- ILMN 02-06-2025
- Dividend Yield
- WDC N/A
- ILMN N/A
- EPS Growth
- WDC N/A
- ILMN N/A
- EPS
- WDC 0.99
- ILMN N/A
- Revenue
- WDC $14,348,000,000.00
- ILMN $4,390,000,000.00
- Revenue This Year
- WDC $31.21
- ILMN N/A
- Revenue Next Year
- WDC $10.85
- ILMN $4.05
- P/E Ratio
- WDC $62.17
- ILMN N/A
- Revenue Growth
- WDC 26.61
- ILMN N/A
- 52 Week Low
- WDC $48.96
- ILMN $97.36
- 52 Week High
- WDC $81.55
- ILMN $156.66
- Technical
- Relative Strength Index (RSI)
- WDC 37.36
- ILMN 40.09
- Support Level
- WDC $58.99
- ILMN $130.31
- Resistance Level
- WDC $67.20
- ILMN $137.69
- Average True Range (ATR)
- WDC 2.15
- ILMN 5.13
- MACD
- WDC -0.83
- ILMN -1.03
- Stochastic Oscillator
- WDC 19.87
- ILMN 21.69
About WDC Western Digital Corporation
Western Digital is a leading vertically integrated supplier of data storage solutions, spanning both hard disk drives and solid-state drives. In the HDD market it forms a practical duopoly with Seagate, and it is the largest global producer of NAND flash chips for SSDs in a joint venture with competitor Kioxia.
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.